|Botanical|| Green / Oolong / BlackTea (Camellia sinensis)
| ||Regular and substantial consumption of green tea may provide protective effect against this type of cancer.|
Increased Fish Consumption
| ||Study subjects who ate two or more servings of fish weekly had a much lower risk for esophageal, stomach, colon, rectum, and pancreatic cancers than those who avoided fish. In fact, the rates of these types of cancer were 30 to 50 percent lower among fish eaters. High fish consumption was also associated with lower risks for cancers of the larynx (30 percent lower risk), endometrial cancer (20 percent lower risk), and ovarian cancer (30 percent lower risk).|
| ||Diets high in meats, fried foods and nitrosamines may increase the risk, while diets high in fruits and vegetables may reduce the risk of pancreatic cancer.|
| ||Studies linking coffee consumption with cancer are conflicting and inconclusive at this point, but there is a suggestion of a higher incidence of cancers of the pancreas, ovaries, bladder, and kidneys in coffee drinkers.|
LDN - Low Dose Naltrexone
| ||This report describes the use of alpha-lipoic acid and LDN in a man with pancreatic cancer. It seems likely that such a program would go far in preventing this condition in someone with an elevated risk. [The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous alpha-Lipoic Acid/Low - Dose Naltrexone Protocol, Burton M. Berkson, Daniel M. Rubin, and Arthur J. Berkson INTEGRATIVE CANCER THERAPIES 5(1); 2006] Disease progression recurred when stopping the program, and progression stopped again on resumption.|
Conventional Drugs / Information
| ||A common asthma drug reduced pancreatic cancer cell growth in laboratory experiments and animal tests, a new study reports.|
A protein called S100P is found in excess amounts in some cancers and is important for pancreatic cancer cell growth and survival. This protein also activates a cell surface protein receptor called RAGE that plays a role in Alzheimer disease, diabetes, and cancer.
A drug called cromolyn, an allergy and asthma treatment, has been shown to bind to proteins similar to S100P. To test cromolyn’s effects on S100P in pancreatic cancer cells, Thiruvengadam Arumugam, Ph.D., Vijaya Ramachandran, Ph.D., and Craig D. Logsdon, Ph.D., of the University of Texas M. D. Anderson Cancer Center in Houston, conducted experiments with the drug in tissue cultures and in mice with implanted pancreatic cancer.
They found that cromolyn bound to S100P, halted the activation of RAGE, and slowed cancer cell growth and survival in cell lines. In mice, the drug slowed pancreatic tumor growth and improved the effectiveness of gemcitabine, a chemotherapy drug used to treat pancreatic cancer.
"Together, these data support the further investigation of cromolyn as a possible treatment for pancreatic cancer," the authors write. [JNCI December 20, 2006]
Digestive Enzymes / (Trial)
| ||Based on preliminary evidence that pancreatic enzymes kill pancreatic cancer cells, it would be prudent to ensure pancreatic sufficiency or use pancreatic enzymes supplementally when the risk of developing pancreatic cancer is increased.|
Dr. Gonzales, M.D. reviewed and published the follow-up results of 11 patients who followed his treatment regime. They lived on average three times longer than expected. Gonzales said all the patients were in an advanced stage of the illness, and their conditions were inoperable. He further stated that "the survival rate at this stage is usually about 4-5 months, but the survival rate for the test patients was 17 1/2 months... I think the pancreatic enzymes do have a powerful anti-cancer effect. We do use diet (fruits and vegetables), we do use coffee enemas, we do use vitamins and minerals. I don't think any of those things kill cancer cells. I do think pancreatic enzymes do." [Nutrition and Cancer 33(2): pp.117-124]
Test AMAS (AntiMalignin Antibody Screen)
Alpha Lipoic Acid
| ||Please see the link between Increased Risk of Pancreatic Cancer and LDN. The dose of Alpha Lipoic Acid used with the patient to increase his survival time was 300 to 600 mg intravenously twice weekly and orally, ALA 300 mg twice daily.|| |